252 related articles for article (PubMed ID: 21548867)
1. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.
Sikiric P; Seiwerth S; Rucman R; Turkovic B; Rokotov DS; Brcic L; Sever M; Klicek R; Radic B; Drmic D; Ilic S; Kolenc D; Vrcic H; Sebecic B
Curr Pharm Des; 2011; 17(16):1612-32. PubMed ID: 21548867
[TBL] [Abstract][Full Text] [Related]
2. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response.
Sikiric P; Seiwerth S; Brcic L; Blagaic AB; Zoricic I; Sever M; Klicek R; Radic B; Keller N; Sipos K; Jakir A; Udovicic M; Tonkic A; Kokic N; Turkovic B; Mise S; Anic T
Inflammopharmacology; 2006 Dec; 14(5-6):214-21. PubMed ID: 17186181
[TBL] [Abstract][Full Text] [Related]
3. Duodenocutaneous fistula in rats as a model for "wound healing-therapy" in ulcer healing: the effect of pentadecapeptide BPC 157, L-nitro-arginine methyl ester and L-arginine.
Skorjanec S; Kokot A; Drmic D; Radic B; Sever M; Klicek R; Kolenc D; Zenko A; Lovric Bencic M; Belosic Halle Z; Situm A; Zivanovic Posilovic G; Masnec S; Suran J; Aralica G; Seiwerth S; Sikiric P
J Physiol Pharmacol; 2015 Aug; 66(4):581-90. PubMed ID: 26348082
[TBL] [Abstract][Full Text] [Related]
4. Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157.
Sikiric P; Seiwerth S; Rucman R; Turkovic B; Rokotov DS; Brcic L; Sever M; Klicek R; Radic B; Drmic D; Ilic S; Kolenc D; Aralica G; Safic H; Suran J; Rak D; Dzidic S; Vrcic H; Sebecic B
Curr Pharm Des; 2013; 19(1):76-83. PubMed ID: 22950504
[TBL] [Abstract][Full Text] [Related]
5. Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy.
Cesarec V; Becejac T; Misic M; Djakovic Z; Olujic D; Drmic D; Brcic L; Rokotov DS; Seiwerth S; Sikiric P
Eur J Pharmacol; 2013 Feb; 701(1-3):203-12. PubMed ID: 23220707
[TBL] [Abstract][Full Text] [Related]
6. Nonsteroidal anti-inflammatory drugs-induced failure of lower esophageal and pyloric sphincter and counteraction of sphincters failure with stable gatric pentadecapeptide BPC 157 in rats.
Vitaic S; Stupnisek M; Drmic D; Bauk L; Kokot A; Klicek R; Vcev A; Luetic K; Seiwerth S; Sikiric P
J Physiol Pharmacol; 2017 Apr; 68(2):265-272. PubMed ID: 28614776
[TBL] [Abstract][Full Text] [Related]
7. Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Therapy.
Sikiric P; Drmic D; Sever M; Klicek R; Blagaic AB; Tvrdeic A; Kralj T; Kovac KK; Vukojevic J; Siroglavic M; Gojkovic S; Krezic I; Pavlov KH; Rasic D; Mirkovic I; Kokot A; Skrtic A; Seiwerth S
Curr Pharm Des; 2020; 26(25):2991-3000. PubMed ID: 32329684
[TBL] [Abstract][Full Text] [Related]
8. An experimental model of prolonged esophagitis with sphincter failure in the rat and the therapeutic potential of gastric pentadecapeptide BPC 157.
Petrovic I; Dobric I; Drvis P; Shejbal D; Brcic L; Blagaic AB; Batelja L; Kokic N; Tonkic A; Mise S; Baotic T; Staresinic M; Radic B; Jakir A; Vuksic T; Anic T; Seiwerth S; Sikiric P
J Pharmacol Sci; 2006 Nov; 102(3):269-77. PubMed ID: 17116974
[TBL] [Abstract][Full Text] [Related]
9. Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system.
Klicek R; Sever M; Radic B; Drmic D; Kocman I; Zoricic I; Vuksic T; Ivica M; Barisic I; Ilic S; Berkopic L; Vrcic H; Brcic L; Blagaic AB; Coric M; Brcic I; Rokotov DS; Anic T; Seiwerth S; Sikiric P
J Pharmacol Sci; 2008 Sep; 108(1):7-17. PubMed ID: 18818478
[TBL] [Abstract][Full Text] [Related]
10. Gastric pentadecapeptide BPC 157 and short bowel syndrome in rats.
Sever M; Klicek R; Radic B; Brcic L; Zoricic I; Drmic D; Ivica M; Barisic I; Ilic S; Berkopic L; Blagaic AB; Coric M; Kolenc D; Vrcic H; Anic T; Seiwerth S; Sikiric P
Dig Dis Sci; 2009 Oct; 54(10):2070-83. PubMed ID: 19093208
[TBL] [Abstract][Full Text] [Related]
11. Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions.
Ilic S; Drmic D; Franjic S; Kolenc D; Coric M; Brcic L; Klicek R; Radic B; Sever M; Djuzel V; Filipovic M; Djakovic Z; Stambolija V; Blagaic AB; Zoricic I; Gjurasin M; Stupnisek M; Romic Z; Zarkovic K; Dzidic S; Seiwerth S; Sikiric P
Life Sci; 2011 Mar; 88(11-12):535-42. PubMed ID: 21295044
[TBL] [Abstract][Full Text] [Related]
12. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL14736, Pliva, Croatia) heals ileoileal anastomosis in the rat.
Vuksic T; Zoricic I; Brcic L; Sever M; Klicek R; Radic B; Cesarec V; Berkopic L; Keller N; Blagaic AB; Kokic N; Jelic I; Geber J; Anic T; Seiwerth S; Sikiric P
Surg Today; 2007; 37(9):768-77. PubMed ID: 17713731
[TBL] [Abstract][Full Text] [Related]
13. Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME.
Djakovic Z; Djakovic I; Cesarec V; Madzarac G; Becejac T; Zukanovic G; Drmic D; Batelja L; Zenko Sever A; Kolenc D; Pajtak A; Knez N; Japjec M; Luetic K; Stancic-Rokotov D; Seiwerth S; Sikiric P
World J Gastroenterol; 2016 Nov; 22(41):9127-9140. PubMed ID: 27895400
[TBL] [Abstract][Full Text] [Related]
14. Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157.
Sikiric P; Seiwerth S; Rucman R; Turkovic B; Rokotov DS; Brcic L; Sever M; Klicek R; Radic B; Drmic D; Ilic S; Kolenc D; Stambolija V; Zoricic Z; Vrcic H; Sebecic B
Curr Med Chem; 2012; 19(1):126-32. PubMed ID: 22300085
[TBL] [Abstract][Full Text] [Related]
15. Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on Gastrointestinal, Liver, and Brain Lesions, Failed Anastomosis, and Intestinal Adaptation Deterioration in 24 Hour-Short-Bowel Rats.
Lojo N; Rasic Z; Zenko Sever A; Kolenc D; Vukusic D; Drmic D; Zoricic I; Sever M; Seiwerth S; Sikiric P
PLoS One; 2016; 11(9):e0162590. PubMed ID: 27627764
[TBL] [Abstract][Full Text] [Related]
16. Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole.
Skorjanec S; Dolovski Z; Kocman I; Brcic L; Blagaic Boban A; Batelja L; Coric M; Sever M; Klicek R; Berkopic L; Radic B; Drmic D; Kolenc D; Ilic S; Cesarec V; Tonkic A; Zoricic I; Mise S; Staresinic M; Ivica M; Lovric Bencic M; Anic T; Seiwerth S; Sikiric P
Dig Dis Sci; 2009 Jan; 54(1):46-56. PubMed ID: 18649140
[TBL] [Abstract][Full Text] [Related]
17. BPC 157 therapy to detriment sphincters failure-esophagitis-pancreatitis in rat and acute pancreatitis patients low sphincters pressure.
Petrovic I; Dobric I; Drmic D; Sever M; Klicek R; Radic B; Brcic L; Kolenc D; Zlatar M; Kunjko K; Jurcic D; Martinac M; Rasic Z; Boban Blagaic A; Romic Z; Seiwerth S; Sikiric P
J Physiol Pharmacol; 2011 Oct; 62(5):527-34. PubMed ID: 22204800
[TBL] [Abstract][Full Text] [Related]
18. Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator.
Sikiric P; Seiwerth S; Brcic L; Sever M; Klicek R; Radic B; Drmic D; Ilic S; Kolenc D
Curr Pharm Des; 2010; 16(10):1224-34. PubMed ID: 20166993
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME.
Drmic D; Kolenc D; Ilic S; Bauk L; Sever M; Zenko Sever A; Luetic K; Suran J; Seiwerth S; Sikiric P
World J Gastroenterol; 2017 Aug; 23(29):5304-5312. PubMed ID: 28839430
[TBL] [Abstract][Full Text] [Related]
20. Abdominal aorta anastomosis in rats and stable gastric pentadecapeptide BPC 157, prophylaxis and therapy.
Hrelec M; Klicek R; Brcic L; Brcic I; Cvjetko I; Seiwerth S; Sikiric P
J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():161-5. PubMed ID: 20388960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
